Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Mirabegron (E.R.) 50mg
Therapeutic Category
Urology
Dosage Form
Tablet
Packaging Type
Alu-Alu
Packaging
10x10
Price
₹399/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Miratyle 50 Tablet contains Mirabegron (E.R.) 50mg, an extended-release formulation of a beta-3 adrenergic agonist. It is specifically designed to treat the symptoms of overactive bladder (OAB), including urinary urgency, increased frequency, and urge urinary incontinence. Mirabegron works by selectively activating beta-3 adrenergic receptors in the bladder, which relaxes the detrusor muscle during the storage phase of the urinary cycle. This enhances the bladder's capacity to hold urine and reduces the symptoms of urgency and frequency, providing significant relief to individuals with OAB.
The extended-release formulation ensures sustained therapeutic levels in the body, allowing for once-daily dosing and improved patient compliance. Miratyle 50 Tablet is a preferred choice for individuals who may not tolerate anticholinergic medications due to their side effects like dry mouth and constipation.
Common side effects include increased blood pressure, headache, nasopharyngitis, and urinary tract infections. Rarely, dizziness or gastrointestinal discomfort may occur.
For the treatment of overactive bladder (OAB) symptoms, including urgency, frequency, and urge urinary incontinence.
Use only under medical supervision. Inform your doctor if you have high blood pressure, severe kidney or liver impairment, or are pregnant or breastfeeding. Adhere to the prescribed dosage.
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic Acid (600mg) SR
Composition : Allylestrenol (5mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Gabapentin (300mg) + Methylcobalamin (500mcg)
Composition : Myo Inositol 1000 mg + L-Methylfolate 100 mcg + Vitamin D3 1000 IU
Composition : Myo Inositol 2000mg + Pyridoxal 5 Phosphate 2.4mg + Calcium 1000mg + Vitamin D3 (600IU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Mirabegron 50 mg Extended Release (ER) Tablet is a urology medicine used for the treatment of overactive bladder (OAB), characterized by symptoms such as urinary urgency, frequent urination, and urge incontinence. It is a beta-3 adrenergic agonist that relaxes the bladder muscle and improves bladder capacity, helping patients gain better urinary control. The 50 mg strength is commonly used when stronger symptom control is required, making it a key product in the urology and geriatric care segment.
Medical distributors and wholesalers can benefit from steady demand from urologists, gynecologists, and physicians, especially due to the rising incidence of bladder dysfunction in the aging population. Overactive bladder is a chronic condition, so patients often require long-term treatment, ensuring repeat prescriptions and consistent sales growth.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in urology, gynecology, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from growing geriatric population, increasing awareness of urinary disorders, and strong specialist-driven prescriptions, making it a stable, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in urology and chronic care products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the urology and geriatric healthcare segment.